Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection
| Status: | Completed |
|---|---|
| Conditions: | HIV / AIDS |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/17/2016 |
| Start Date: | March 2009 |
| End Date: | April 2016 |
Validate a simple and cost-effective Nucleic Acid Test for HIV Detection in order to develop
a rapid, highly sensitive and specific, one-stage test for the diagnosis of HIV infection.
Blood samples collected will be assayed using the BioHelix Corporation helicase-dependent
amplification or the Cepheid Xpert HIV-1 Quant Assay. A false negative or false positive
rate of >1.0% would make this test unacceptable as a screening test for HIV viremia.
a rapid, highly sensitive and specific, one-stage test for the diagnosis of HIV infection.
Blood samples collected will be assayed using the BioHelix Corporation helicase-dependent
amplification or the Cepheid Xpert HIV-1 Quant Assay. A false negative or false positive
rate of >1.0% would make this test unacceptable as a screening test for HIV viremia.
Inclusion Criteria:
- Current patient in the Medical Faculty Associates Infectious Diseases (ID) clinic
with known HIV infection
- Suspected to be viremic at the time of their clinic visit based on history and/or
current symptoms
- Able to provide informed consent
- 18 Years or older
Exclusion Criteria:
- Patient unable to provide informed consent.
- Pregnancy
We found this trial at
1
site
Click here to add this to my saved trials
